Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-245718
Filing Date
2022-09-15
Accepted
2022-09-15 17:16:15
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d403591d424b5.htm 424B5 482544
2 GRAPHIC g403591g01a53.jpg GRAPHIC 32765
3 GRAPHIC g403591g05a05.jpg GRAPHIC 77340
  Complete submission text file 0001193125-22-245718.txt   634132
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-256229 | Film No.: 221246465
SIC: 2834 Pharmaceutical Preparations